Carter Charles Ross
SEC insider (Form 3/4/5 filer). CIK 0001779359. Chief Financial Officer at Ovid Therapeutics Inc. (OVID). 1 reported Form 4/5 transaction since Sep 2024; latest on Jul 6, 2026. Located in NEW YORK, NY.
Companies Carter Charles Ross has filed insider reports for
- Ovid Therapeutics Inc. (OVID): Officer, Chief Financial Officer
Carter Charles Ross
CIK: 0001779359
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OVID
Ovid Therapeutics Inc.
Officer